The Biden administration released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.
The massive private insurance conglomerates all are owned by the same people as the pharma conglomerates. They already get massive discount rates and are basically self dealing anyway.
The whole house of cards is to extract maximum profits from public healthcare funds.
Basically nobody pays the list price other than Medicaid/Medicare or people with no coverage at all.
Oh absolutely, agreed on all points. I was just saying there’s a possibility others beyond Medicare recipients might see some improvement in prices on these drugs as a result of this, but it doesn’t address the many many root problems with our current system like you say. Americans are still going to be massively overpaying on drugs. At least one small step in the right direction though, Medicare paying less for drugs benefits us all indirectly too some since everyone is paying into that with taxes.
So true, even a baby step is better than the o motion or even backpedalling from the last 30 years.